Verition Fund Management LLC

Position in TERN — Terns Pharmaceuticals, Inc.

CIK 1454027 GREENWICH, CT

Back to TERN Full portfolio

Position in TERN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

+$0 QoQ

Shares Held

802,293

+6185.1% QoQ

Ownership

0.694%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in TERN Over Time

Shares Held

Position Value (USD)

Derivatives in TERN

reported options exposure · as of Mar 31, 2026

CallValue

CallShares

PutValue

PutShares

750,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Verition Fund Management LLC holds $152,220,097 across 64 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	438,746	$30,997,404
2	APGE	Apogee Therapeutics, Inc.	159,256	$21,138,048
3	ABVX	Abivax S.A.	105,791	$14,097,708
4	IDYA	IDEAYA Biosciences, Inc.	184,054	$6,859,692
5	SNDX	Syndax Pharmaceuticals Inc	304,939	$6,665,966
6	MRVI	Maravai Lifesciences Holdings, Inc.	777,738	$4,853,085
7	CYTK	Cytokinetics Inc	54,889	$4,675,993
8	RPRX	Royalty Pharma plc	75,000	$4,205,250

All Filings in TERN

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	—	750,000	—	Put	Sole	2026-05-15
2026-03-31	—	802,293	+6185.1%	Shares	Sole	2026-05-15
2025-12-31	—	12,765	-34.0%	Shares	Sole	2026-02-13
2024-12-31	—	19,350	-5.6%	Shares	Sole	2025-02-14
2023-06-30	—	20,500	-19.9%	Shares	Sole	2023-08-14
2023-03-31	—	25,590	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.